* Strategies to Save for Retirement * Asset Allocation for My Age * Best IRA Brokerage Accounts * Social Security 101 * How to Maximize Social Security?
There may be a niche in the market to explore if Viking's candidate proves more effective over short time frames despite being more unpleasant.
But even if the biotech produces positive results for its jab and gets it approved and commercialized, and eventually does the same for its pill form, it'll still be trying to enter a crowded market that's increasingly cornered by the incumbents.
Cost basis and return based on previous market day close.
Given this setup, is now a good time to buy Viking's stock?